These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 7898676
1. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Ferré S, O'Connor WT, Snaprud P, Ungerstedt U, Fuxe K. Neuroscience; 1994 Dec; 63(3):765-73. PubMed ID: 7898676 [Abstract] [Full Text] [Related]
2. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Díaz-Cabiale Z, Vivó M, Del Arco A, O'Connor WT, Harte MK, Müller CE, Martínez E, Popoli P, Fuxe K, Ferré S. Neurosci Lett; 2002 May 17; 324(2):154-8. PubMed ID: 11988350 [Abstract] [Full Text] [Related]
3. Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia. O'Connor WT. J Neurosci Methods; 2001 Aug 15; 109(1):31-9. PubMed ID: 11489297 [Abstract] [Full Text] [Related]
4. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Hauber W, Münkle M. Eur J Pharmacol; 1997 Apr 04; 323(2-3):127-31. PubMed ID: 9128830 [Abstract] [Full Text] [Related]
5. Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum. Díaz-Cabiale Z, Hurd Y, Guidolin D, Finnman UB, Zoli M, Agnati LF, Vanderhaeghen JJ, Fuxe K, Ferré S. Neuroreport; 2001 Jul 03; 12(9):1831-4. PubMed ID: 11435907 [Abstract] [Full Text] [Related]
6. Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum. Ferré S, Schwarcz R, Li XM, Snaprud P, Ogren SO, Fuxe K. Psychopharmacology (Berl); 1994 Nov 03; 116(3):279-84. PubMed ID: 7892417 [Abstract] [Full Text] [Related]
7. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus. Lillrank SM, Lipska BK, Weinberger DR, Fredholm BB, Fuxe K, Ferré S. Neurochem Int; 1999 Mar 03; 34(3):235-44. PubMed ID: 10355490 [Abstract] [Full Text] [Related]
8. Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. Mingote S, Font L, Farrar AM, Vontell R, Worden LT, Stopper CM, Port RG, Sink KS, Bunce JG, Chrobak JJ, Salamone JD. J Neurosci; 2008 Sep 03; 28(36):9037-46. PubMed ID: 18768698 [Abstract] [Full Text] [Related]
10. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Marshall JF, Henry BL, Billings LM, Hoover BR. Neuroscience; 2001 Sep 03; 105(2):365-78. PubMed ID: 11672604 [Abstract] [Full Text] [Related]
11. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K. Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519 [Abstract] [Full Text] [Related]
12. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release. Kurokawa M, Kirk IP, Kirkpatrick KA, Kase H, Richardson PJ. Br J Pharmacol; 1994 Sep 15; 113(1):43-8. PubMed ID: 7812630 [Abstract] [Full Text] [Related]
13. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Ferré S. Psychopharmacology (Berl); 1997 Sep 15; 133(2):107-20. PubMed ID: 9342776 [Abstract] [Full Text] [Related]
14. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias. Antonelli T, Fuxe K, Agnati L, Mazzoni E, Tanganelli S, Tomasini MC, Ferraro L. J Neurol Sci; 2006 Oct 25; 248(1-2):16-22. PubMed ID: 16765381 [Abstract] [Full Text] [Related]
15. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. Andersson JL, Nomikos GG, Marcus M, Hertel P, Mathé JM, Svensson TH. Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct 25; 352(4):374-85. PubMed ID: 8532065 [Abstract] [Full Text] [Related]
16. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. Ferré S, O'Connor WT, Fuxe K, Ungerstedt U. J Neurosci; 1993 Dec 25; 13(12):5402-6. PubMed ID: 8254382 [Abstract] [Full Text] [Related]
17. GABA(A) agents injected into the ventral pallidum differentially affect dopaminergic pivoting and cholinergic circling elicited from the shell of the nucleus accumbens. Kitamura M, Ikeda H, Koshikawa N, Cools AR. Neuroscience; 2001 Dec 25; 104(1):117-27. PubMed ID: 11311536 [Abstract] [Full Text] [Related]
19. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S. J Neurochem; 2004 Nov 25; 91(4):873-80. PubMed ID: 15525341 [Abstract] [Full Text] [Related]
20. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors. Johansson B, Georgiev V, Fredholm BB. Neuroscience; 1997 Oct 25; 80(4):1187-207. PubMed ID: 9284070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]